RIL
OCUL icon

Rothschild Investment LLC’s Ocular Therapeutix OCUL Stock Holding History

Rothschild Investment LLC’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.64K Buy
473
+153
+48% +$1.39K ﹤0.01% 2319
2026
Q1 		$2.71K Buy
320
+66
+26% +$629 ﹤0.01% 2399
2025
Q4 		$3.08K Buy
254
+9
+4% +$109 ﹤0.01% 2145
2025
Q3 		$2.86K Sell
245
-60
-20% -$717 ﹤0.01% 2000
2025
Q2 		$2.83K Buy
305
+10
+3% +$78 ﹤0.01% 1826
2025
Q1 		$2.16K Buy
295
+85
+40% +$653 ﹤0.01% 1849
2024
Q4 		$1.79K Buy
210
+40
+24% +$390 ﹤0.01% 1867
2024
Q3 		$1.48K Buy
170
+100
+143% +$824 ﹤0.01% 1895
2024
Q2 		$479 Buy
70
+55
+367% +$340 ﹤0.01% 2048
2024
Q1 		$137 Buy
+15
New +$106 ﹤0.01% 1984

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Rothschild Investment LLC's OCUL Position: Q2 2026 in Review

Rothschild Investment LLC increased its Ocular Therapeutix (OCUL) stake by 48% in Q2 2026, buying an estimated $1.39K and bringing the position to 473 shares worth $4.64K. The position accounts for ﹤0.01% of the portfolio, ranked #2319.

Rothschild Investment LLC first reported a position in OCUL in Q1 2024 and has held it in 10 quarters since. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Rothschild Investment LLC held 473 shares of Ocular Therapeutix worth $4.64K as of Q2 2026.
  • Rothschild Investment LLC bought 153 Ocular Therapeutix shares in Q2 2026, an estimated $1.39K.
  • Ocular Therapeutix made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2319 holding.
  • Rothschild Investment LLC first reported a position in Ocular Therapeutix in Q1 2024 and has held it in 10 quarters since.
  • 262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.